This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Byrne KM, Sheldon SL, Flegel WA. Organization and management of an accredited Specialist in Blood Banking (SBB) technology program. Transfusion 2010;50:1612–7.ByrneKMSheldonSLFlegelWA.Organization and management of an accredited Specialist in Blood Banking (SBB) technology program.Transfusion2010;50:1612–7.10.1111/j.1537-2995.2010.02737.x339091221175473Search in Google Scholar
Commission on Accreditation of Allied Health Education Programs. Standards and Guidelines. Available from https://www.caahep.org/Program-Directors/Standards.aspx. Accessed 8 October 2019.Commission on Accreditation of Allied Health Education Programs.Standards and Guidelines. Available from https://www.caahep.org/Program-Directors/Standards.aspx. Accessed 8 October 2019.Search in Google Scholar
Bowman CA, Yu M, Cottler-Fox M. Evaluation of methods for preparing and thawing cryopreserved CD34+ and CD34– cell lines for use as reagents in flow cytometry of hematopoietic progenitor cells. Transfusion 1996;36:985–8.BowmanCAYuMCottler-FoxM.Evaluation of methods for preparing and thawing cryopreserved CD34+ and CD34– cell lines for use as reagents in flow cytometry of hematopoietic progenitor cells.Transfusion1996;36:985–8.10.1046/j.1537-2995.1996.36111297091743.x8937409Search in Google Scholar
Marincola FM, Rivoltini L, Salgaller ML, Player M, Rosenberg SA. Differential anti-MART-1/MelanA CTL activity in peripheral blood of HLA-A2 melanoma patients in comparison to healthy donors: evidence of in vivo priming by tumor cells. J Immunother Emphasis Tumor Immunol 1996;19:266–77.MarincolaFMRivoltiniLSalgallerMLPlayerMRosenbergSA.Differential anti-MART-1/MelanA CTL activity in peripheral blood of HLA-A2 melanoma patients in comparison to healthy donors: evidence of in vivo priming by tumor cells.J Immunother Emphasis Tumor Immunol1996;19:266–77.10.1097/00002371-199607000-000038877721Search in Google Scholar
Player MA, Barracchini KC, Simonis TB, et al. Differences in frequency distribution of HLA-A2 subtypes between North American and Italian white melanoma patients: relevance for epitope specific vaccination protocols. J Immunother Emphasis Tumor Immunol 1996;19:357–63.PlayerMABarracchiniKCSimonisTB,Differences in frequency distribution of HLA-A2 subtypes between North American and Italian white melanoma patients: relevance for epitope specific vaccination protocols.J Immunother Emphasis Tumor Immunol1996;19:357–63.10.1097/00002371-199609000-000058941875Search in Google Scholar
Chun H, Cipolone K, Procter J, Stroncek DF. Granulocyte storage and antigen stability. Transfusion 1999;39:983–90.ChunHCipoloneKProcterJStroncekDF.Granulocyte storage and antigen stability.Transfusion1999;39:983–90.10.1046/j.1537-2995.1999.39090983.x10533825Search in Google Scholar
Cowley H, Wojda U, Cipolone KM, Procter JL, Stroncek DF, Miller JL. Biotinylation modifies red cell antigens. Transfusion 1999;39:163–8.CowleyHWojdaUCipoloneKMProcterJLStroncekDFMillerJL.Biotinylation modifies red cell antigens.Transfusion1999;39:163–8.10.1046/j.1537-2995.1999.39299154730.x10037126Search in Google Scholar
Langston MM, Procter JL, Cipolone KM, Stroncek DF. Evaluation of the gel system for ABO grouping and D typing. Transfusion 1999;39:300–5.LangstonMMProcterJLCipoloneKMStroncekDF.Evaluation of the gel system for ABO grouping and D typing.Transfusion1999;39:300–5.10.1046/j.1537-2995.1999.39399219288.x10204594Search in Google Scholar
Kiekhaefer KM, Cipolone KM, Procter JL, Matsuo K, Stroncek DF. Detection of granulocyte antibodies by flow cytometry without the use of pure granulocyte isolates. Immunohematology 2001;17:70–5.KiekhaeferKMCipoloneKMProcterJLMatsuoKStroncekDF.Detection of granulocyte antibodies by flow cytometry without the use of pure granulocyte isolates.Immunohematology2001;17:70–5.10.21307/immunohematology-2019-550Search in Google Scholar
Moses LA, Stroncek DF, Cipolone KM, Marincola FM. Detection of HLA antibodies by using flow cytometry and latex beads coated with HLA antigens. Transfusion 2000;40:861–6.MosesLAStroncekDFCipoloneKMMarincolaFM.Detection of HLA antibodies by using flow cytometry and latex beads coated with HLA antigens.Transfusion2000;40:861–6.10.1046/j.1537-2995.2000.40070861.x10924616Search in Google Scholar
Smith JD, Leitman SF. Filtration of RBC units: effect of storage time and temperature on filter performance. Transfusion 2000;40:521–6.SmithJDLeitmanSF.Filtration of RBC units: effect of storage time and temperature on filter performance.Transfusion2000;40:521–6.10.1046/j.1537-2995.2000.40050521.x10827253Search in Google Scholar
Stroncek DF, Carter LB, Procter JL, Dale JK, Straus SE. RBC autoantibodies in autoimmune lymphoproliferative syndrome. Transfusion 2001;41:18–23.StroncekDFCarterLBProcterJLDaleJKStrausSE.RBC autoantibodies in autoimmune lymphoproliferative syndrome.Transfusion2001;41:18–23.10.1046/j.1537-2995.2001.41010018.x11161240Search in Google Scholar
Caruccio L, Byrne K, Procter J, Stroncek D. A novel method using formamide for the elution of antibodies from erythrocytes. Vox Sang 2002;83:63–9.CaruccioLByrneKProcterJStroncekD.A novel method using formamide for the elution of antibodies from erythrocytes.Vox Sang2002;83:63–9.10.1046/j.1423-0410.2002.00181.x12100391Search in Google Scholar
Chambers DR, Procter J, Muratova O, et al. In vitro RBC exposure to Plasmodium falciparum has no effect on RBC antigen expression. Transfus Med 2002;12:213–9.ChambersDRProcterJMuratovaO,In vitro RBC exposure to Plasmodium falciparum has no effect on RBC antigen expression.Transfus Med2002;12:213–9.10.1046/j.1365-3148.2002.00375.x12071878Search in Google Scholar
Patel HD, Byrne KM, Horne M, Leitman SF, Stroncek DF. Factors affecting the formation of white particulate matter in red blood cell components. Transfusion 2005;45:1127–32.PatelHDByrneKMHorneMLeitmanSFStroncekDF.Factors affecting the formation of white particulate matter in red blood cell components.Transfusion2005;45:1127–32.10.1111/j.1537-2995.2005.04351.x15987357Search in Google Scholar
Tudisco C, Jett BW, Byrne K, Oblitas J, Leitman SF, Stroncek DF. The value of pH as a quality control indicator for apheresis platelets. Transfusion 2005;45:773–8.TudiscoCJettBWByrneKOblitasJLeitmanSFStroncekDF.The value of pH as a quality control indicator for apheresis platelets.Transfusion2005;45:773–8.10.1111/j.1537-2995.2005.04344.x15847668Search in Google Scholar
Greco VA, Byrne KM, Procter JL, Stroncek DF. Detection of antibodies in acid eluates with the gel microcolumn assay. Transfusion 2002;42:698–701.GrecoVAByrneKMProcterJLStroncekDF.Detection of antibodies in acid eluates with the gel microcolumn assay.Transfusion2002;42:698–701.10.1046/j.1537-2995.2002.00108.x12147021Search in Google Scholar
Stroncek DF, Rainer T, Sharon V, et al. Sickle Hb polymerization in RBC components from donors with sickle cell trait prevents effective WBC reduction by filtration. Transfusion 2002;42:1466–72.StroncekDFRainerTSharonV,Sickle Hb polymerization in RBC components from donors with sickle cell trait prevents effective WBC reduction by filtration.Transfusion2002;42:1466–72.10.1046/j.1537-2995.2002.00206.x12421220Search in Google Scholar
Fisher V, Khuu H, David-Ocampo V, et al. Analysis of the recovery of cryopreserved and thawed CD34+ and CD3+ cells collected for hematopoietic transplantation. Transfusion 2014;54:1088–92.FisherVKhuuHDavid-OcampoV,Analysis of the recovery of cryopreserved and thawed CD34+ and CD3+ cells collected for hematopoietic transplantation.Transfusion2014;54:1088–92.10.1111/trf.12428398317124117879Search in Google Scholar
Renoud KJ, Barracchini K, Byrne KM, et al. KEL6 and KEL7 genotyping with sequence-specific primers. Transfusion 2006;46:1510–4.RenoudKJBarracchiniKByrneKM,KEL6 and KEL7 genotyping with sequence-specific primers.Transfusion2006;46:1510–4.10.1111/j.1537-2995.2006.00937.x16965577Search in Google Scholar
Schmid P, Huvard MJ, Lee-Stroka AH, Lee JY, Byrne KM, Flegel WA. Red blood cell preservation by droplet freezing with polyvinylpyrrolidone or sucrose-dextrose and by bulk freezing with glycerol. Transfusion 2011;51: 2703–8.SchmidPHuvardMJLee-StrokaAHLeeJYByrneKMFlegelWA.Red blood cell preservation by droplet freezing with polyvinylpyrrolidone or sucrose-dextrose and by bulk freezing with glycerol.Transfusion2011;51:2703–8.10.1111/j.1537-2995.2011.03258.x347080321790629Search in Google Scholar
Schmid P, Ravenell KR, Sheldon SL, Flegel WA. DARC alleles and Duffy phenotypes in African Americans. Transfusion 2012;52:1260–7.SchmidPRavenellKRSheldonSLFlegelWA.DARC alleles and Duffy phenotypes in African Americans.Transfusion2012;52:1260–7.10.1111/j.1537-2995.2011.03431.x337402422082243Search in Google Scholar
Woods I, Tawab-Amiri A, Byrne K, Sabatino M, Stroncek DF. Pilot analysis of cytokines levels in stored granulocyte-colony-stimulating factor-mobilized peripheral blood stem cell concentrates. Transfusion 2010;50: 2011–5.WoodsITawab-AmiriAByrneKSabatinoMStroncekDF.Pilot analysis of cytokines levels in stored granulocyte-colony-stimulating factor-mobilized peripheral blood stem cell concentrates.Transfusion2010;50:2011–5.10.1111/j.1537-2995.2010.02695.x297400920492614Search in Google Scholar
Ackley RJ, Lee-Stroka AH, Bryant BJ, Stroncek DF, Byrne KM. Cryopreserving and deglycerolizing sickle cell trait red blood cell components using an automated cell-processing system. Immunohematology 2008;24:107–12.AckleyRJLee-StrokaAHBryantBJStroncekDFByrneKM.Cryopreserving and deglycerolizing sickle cell trait red blood cell components using an automated cell-processing system.Immunohematology2008;24:107–12.10.21307/immunohematology-2019-281Search in Google Scholar
Grose HL, Byrne KM, Salata JM, Rentas FJ, Stroncek DF. In vitro variables of red blood cell components collected by apheresis and frozen 6 and 14 days after collection. Transfusion 2006;46:1178–83.GroseHLByrneKMSalataJMRentasFJStroncekDF.In vitro variables of red blood cell components collected by apheresis and frozen 6 and 14 days after collection.Transfusion2006;46:1178–83.10.1111/j.1537-2995.2006.00868.x16836565Search in Google Scholar
Lodermeier MA, Byrne KM, Flegel WA. Red blood cell sedimentation of apheresis granulocytes. Transfusion 2017;57:2551–2.LodermeierMAByrneKMFlegelWA.Red blood cell sedimentation of apheresis granulocytes.Transfusion2017;57:2551–2.10.1111/trf.14251565640428815621Search in Google Scholar
Reese EM, Nelson RC, Flegel WA, Byrne KM, Booth GS. Critical value reporting in transfusion medicine: a survey of communication practices in U.S. facilities. Am J Clin Pathol 2017;147:492–9.ReeseEMNelsonRCFlegelWAByrneKMBoothGS.Critical value reporting in transfusion medicine: a survey of communication practices in U.S. facilities.Am J Clin Pathol2017;147:492–9.10.1093/ajcp/aqx025584837928371931Search in Google Scholar
Tynuv M, Flegel WA. Quality improvement with platelet additive solution for safer out-of-group platelet transfusions. Immunohematology 2019;35:108–15.TynuvMFlegelWA.Quality improvement with platelet additive solution for safer out-of-group platelet transfusions.Immunohematology2019;35:108–15.10.21307/immunohematology-2020-024Search in Google Scholar
Flegel WA, Byrne KM, Klein HG. Flashback 1997: collection of hematopoietic progenitor cells by peripheral blood apheresis after stimulation with granulocyte-colony-stimulating factor. Transfusion 2017;57:3067–8.FlegelWAByrneKMKleinHG.Flashback 1997: collection of hematopoietic progenitor cells by peripheral blood apheresis after stimulation with granulocyte-colony-stimulating factor.Transfusion2017;57:3067–8.10.1111/trf.14332576555228924982Search in Google Scholar
Ackley RJ, Byrne KM, Weddington PE. Anti-P1: don’t miss the obvious. Immunohematology 2007;23:130–2.AckleyRJByrneKMWeddingtonPE.Anti-P1: don’t miss the obvious.Immunohematology2007;23:130–2.10.21307/immunohematology-2019-330Search in Google Scholar
Ackley RJ, Byrne KM, Weddington PE. ISBT 128: the future generation. Advance for Medical Laboratory Professionals. 15 January 2007;20–3.AckleyRJByrneKMWeddingtonPE.ISBT 128: the future generation.Advance for Medical Laboratory Professionals. 15 January2007;20–3.Search in Google Scholar
Ackley RJ, Byrne KM. Massive transfusion: when good patients go bad. Advance for Medical Laboratory Professionals. 7 April 2008;28–31.AckleyRJByrneKM.Massive transfusion: when good patients go bad.Advance for Medical Laboratory Professionals. 7 April2008;28–31.Search in Google Scholar
Byrne K, Hughes VC, Procter JL, Rainer TB. Transfusion reaction investigation in a patient with multiple myeloma who has undergone a hematopoietic stem cell transplant. ASCP Tech Sample 2002;I–2.ByrneKHughesVCProcterJLRainerTB.Transfusion reaction investigation in a patient with multiple myeloma who has undergone a hematopoietic stem cell transplant.ASCP Tech Sample2002;I–2.Search in Google Scholar
Byrne KM, Grose HL, Renoud KJ. Detecting platelet contamination: it’s in the bag. Advance for Medical Laboratory Professionals. 26 July 2004;18–21.ByrneKMGroseHLRenoudKJ.Detecting platelet contamination: it’s in the bag.Advance for Medical Laboratory Professionals. 26 July2004;18–21.10.7748/ns.18.52.26.s4215473206Search in Google Scholar
Byrne KM, McGann HL, Weddington PE. Platelets: key player in hemostasis. Advance for Medical Laboratory Professionals. 27 March 2006;18–21.ByrneKMMcGannHLWeddingtonPE.Platelets: key player in hemostasis.Advance for Medical Laboratory Professionals. 27 March2006;18–21.Search in Google Scholar
Byrne KM, Pary PP, Smith CS, Zuehlke JA. Blood: it’s all about quality. Advance for Medical Laboratory Professionals. 10 October 2005;25–30.ByrneKMParyPPSmithCSZuehlkeJA.Blood: it’s all about quality.Advance for Medical Laboratory Professionals. 10 October2005;25–30.Search in Google Scholar
Byrne KM, Shah SS, Woods IHG. Blood banking competency: staffing proficiency saves the day. Advance for Medical Laboratory Professionals. 6 October 2009;1–6. Online exclusive at www.advanceweb.com/MLP.ByrneKMShahSSWoodsIHG.Blood banking competency: staffing proficiency saves the day.Advance for Medical Laboratory Professionals. 6 October2009;1–6. Online exclusive at www.advanceweb.com/MLP
.Search in Google Scholar
Byrne KM, Tudisco CT, Patel HD. Transfusion reaction workup unmasks paroxysmal nocturnal hemoglobinuria in a young girl with acquired aplastic anemia. ASCP Tech Sample 2005; I–1.ByrneKMTudiscoCTPatelHD.Transfusion reaction workup unmasks paroxysmal nocturnal hemoglobinuria in a young girl with acquired aplastic anemia.ASCP Tech Sample2005;I–1.Search in Google Scholar
Patel H, Tudisco C, Byrne KM. Book review: Technical manual, 14th edition. Immunohematology 2003;19:135–7.PatelHTudiscoCByrneKM.Book review: Technical manual, 14th edition.Immunohematology2003;19:135–7.10.21307/immunohematology-2019-495Search in Google Scholar
Byrne KM, Booth GS, Lee JY, Ravenell KR. The importance of antibody detection and identification in the chronically transfused patient. Lab Med 2010;41:261–3.ByrneKMBoothGSLeeJYRavenellKR.The importance of antibody detection and identification in the chronically transfused patient.Lab Med2010;41:261–3.10.1309/LM4ZQD8J8HHENONVSearch in Google Scholar
Byrne KM, Bakker G, Nieves S, Pope M. Hidden treasures in our tool kit: “Aha” moments while resolving serological cases. ASCP Webcast 2010. Available from https://www.ascp.org/content/learning.ByrneKMBakkerGNievesSPopeM.Hidden treasures in our tool kit: “Aha” moments while resolving serological cases.ASCP Webcast2010. Available from https://www.ascp.org/content/learning
.Search in Google Scholar
Byrne KM, Bueno MU, Pelton PB. Transfusion News Question of the Day 2012. Available from https://transfusionnews.com/path-questions. Accessed 8 October 2019.ByrneKMBuenoMUPeltonPB.Transfusion News Question of the Day 2012. Available from https://transfusionnews.com/path-questions. Accessed 8 October 2019.Search in Google Scholar
Fisher VRSM, Trenblay CA, Beaulieu GP, Ward DC. Disseminated intravascular coagulation: laboratory support for management and treatment. Lab Med 2013;44:18–22.FisherVRSMTrenblayCABeaulieuGPWardDC.Disseminated intravascular coagulation: laboratory support for management and treatment.Lab Med2013;44:18–22.10.1309/LMTCAVNHBUGWTP7KSearch in Google Scholar
Byrne KM, Frank EG, Gedman LA, Ivey JR. They’re here! How to prepare your blood bank for inspection. Lab Med 2015;46:e2–6.ByrneKMFrankEGGedmanLAIveyJR.They’re here! How to prepare your blood bank for inspection.Lab Med2015;46:e2–6.10.1309/LMIGNO604GBVAMGM25673749Search in Google Scholar
Byrne KM, Mercado CMC, Nnabue TN, Paige TD, Flegel WA. Inhibition of blood group antibodies by soluble substances. Immunohematology 2019;35:19–22.ByrneKMMercadoCMCNnabueTNPaigeTDFlegelWA.Inhibition of blood group antibodies by soluble substances.Immunohematology2019;35:19–22.10.21307/immunohematology-2020-008Search in Google Scholar
Byrne KM, Gedman L, Ivey JR. Transfusion News Question of the Day 2015. Available from https://transfusionnews.com/path-questions. Accessed 8 October 2019.ByrneKMGedmanLIveyJR.Transfusion News Question of the Day 2015. Available from https://transfusionnews.com/path-questions. Accessed 8 October 2019.Search in Google Scholar
Byrne KM, Simone AR, Biggs ML. Transfusion News Question of the Day 2019. Available from https://transfusionnews.com/path-questions. Accessed 8 October 2019.ByrneKMSimoneARBiggsML.Transfusion News Question of the Day 2019. Available from https://transfusionnews.com/path-questions. Accessed 8 October 2019.Search in Google Scholar
Byrne KM, Tynuv M, Lodermeier M. Transfusion News Question of the Day 2017. Available from https://transfusionnews.com/path-questions. Accessed 8 October 2019.ByrneKMTynuvMLodermeierM.Transfusion News Question of the Day 2017. Available from https://transfusionnews.com/path-questions. Accessed 8 October 2019.Search in Google Scholar
Byrne KM, Levy KY, Reese EM. Following the rules set by accreditation agencies and governing bodies to maintain in-compliance status: applying critical thinking skills when evaluating the need for change in the clinical laboratory. Lab Med 2016;47:e21–6.ByrneKMLevyKYReeseEM.Following the rules set by accreditation agencies and governing bodies to maintain in-compliance status: applying critical thinking skills when evaluating the need for change in the clinical laboratory.Lab Med2016;47:e21–6.10.1093/labmed/lmw007500995026945880Search in Google Scholar
Carter LB, Procter JL, Dale JK, Straus SE, Cantilena CC. Description of serologic features in autoimmune lymphoproliferative syndrome. Transfusion 2000;40:943–8.CarterLBProcterJLDaleJKStrausSECantilenaCC.Description of serologic features in autoimmune lymphoproliferative syndrome.Transfusion2000;40:943–8.10.1046/j.1537-2995.2000.40080943.x10960521Search in Google Scholar
Caruccio L, Bettinotti M, Director-Myska AE, Arthur DC, Stroncek D. The gene overexpressed in polycythemia rubra vera, PRV-1, and the gene encoding a neutrophil alloantigen, NB1, are alleles of a single gene, CD177, in chromosome band 19q13.31. Transfusion 2006;46:441–7.CaruccioLBettinottiMDirector-MyskaAEArthurDCStroncekD.The gene overexpressed in polycythemia rubra vera, PRV-1, and the gene encoding a neutrophil alloantigen, NB1, are alleles of a single gene, CD177, in chromosome band 19q13.31.Transfusion2006;46:441–7.10.1111/j.1537-2995.2006.00741.x16533288Search in Google Scholar
Caruccio L, Bettinotti M, Matsuo K, Sharon V, Stroncek D. Expression of human neutrophil antigen-2a (NB1) is increased in pregnancy. Transfusion 2003;43:357–63.CaruccioLBettinottiMMatsuoKSharonVStroncekD.Expression of human neutrophil antigen-2a (NB1) is increased in pregnancy.Transfusion2003;43:357–63.10.1046/j.1537-2995.2003.00320.x12675722Search in Google Scholar
Caruccio L, Walkovich K, Bettinotti M, Schuller R, Stroncek D. CD177 polymorphisms: correlation between high-frequency single nucleotide polymorphisms and neutrophil surface protein expression. Transfusion 2004;44:77–82.CaruccioLWalkovichKBettinottiMSchullerRStroncekD.CD177 polymorphisms: correlation between high-frequency single nucleotide polymorphisms and neutrophil surface protein expression.Transfusion2004;44:77–82.10.1046/j.0041-1132.2004.00606.x14692971Search in Google Scholar
Fasano RM, Monaco A, Meier ER, et al. RH genotyping in a sickle cell disease patient contributing to hematopoietic stem cell transplantation donor selection and management. Blood 2010;116:2836–8.FasanoRMMonacoAMeierER,RH genotyping in a sickle cell disease patient contributing to hematopoietic stem cell transplantation donor selection and management.Blood2010;116:2836–8.10.1182/blood-2010-04-279372297459120644109Search in Google Scholar
Griffith LM, McCoy JP Jr, Bolan CD, et al. Persistence of recipient plasma cells and anti-donor isohaemagglutinins in patients with delayed donor erythropoiesis after major ABO incompatible non-myeloablative haematopoietic cell transplantation. Br J Haematol 2005;128:668–75.GriffithLMMcCoyJPJrBolanCD,Persistence of recipient plasma cells and anti-donor isohaemagglutinins in patients with delayed donor erythropoiesis after major ABO incompatible non-myeloablative haematopoietic cell transplantation.Br J Haematol2005;128:668–75.10.1111/j.1365-2141.2005.05364.x15725089Search in Google Scholar
Lee-Stroka H, Slezak SL, Adams S, et al. Another example of a KEL1 variant red cell phenotype due to a threonine to serine change at position 193 of Kell glycoprotein. Transfusion 2008;48:925–9.Lee-StrokaHSlezakSLAdamsS,Another example of a KEL1 variant red cell phenotype due to a threonine to serine change at position 193 of Kell glycoprotein.Transfusion2008;48:925–9.10.1111/j.1537-2995.2007.01623.x266654618248571Search in Google Scholar
Lim JB, Provenzano M, Kwon OH, et al. Identification of HLA-A33-restricted CMV pp65 epitopes as common targets for CD8(+) CMV-specific cytotoxic T lymphocytes. Exp Hematol 2006;34:296–307.LimJBProvenzanoMKwonOH,Identification of HLA-A33-restricted CMV pp65 epitopes as common targets for CD8(+) CMV-specific cytotoxic T lymphocytes.Exp Hematol2006;34:296–307.10.1016/j.exphem.2005.12.00616543064Search in Google Scholar
McGann H, Wenk RE. Alloimmunization to the D antigen by a patient with weak D type 21. Immunohematology 2010;26:27–9.McGannHWenkRE.Alloimmunization to the D antigen by a patient with weak D type 21.Immunohematology2010;26:27–9.10.21307/immunohematology-2019-197Search in Google Scholar
Montemayor-Garcia C, Karagianni P, Stiles DA, et al. Genomic coordinates and continental distribution of 120 blood group variants reported by the 1000 Genomes Project. Transfusion 2018;58:2693–704.Montemayor-GarciaCKaragianniPStilesDA,Genomic coordinates and continental distribution of 120 blood group variants reported by the 1000 Genomes Project.Transfusion2018;58:2693–704.10.1111/trf.14953730286030312480Search in Google Scholar
Quillen K, Sheldon SL, Daniel-Johnson JA, Lee-Stroka AH, Flegel WA. A practical strategy to reduce the risk of passive hemolysis by screening plateletpheresis donors for high-titer ABO antibodies. Transfusion 2011;51:92–6.QuillenKSheldonSLDaniel-JohnsonJALee-StrokaAHFlegelWA.A practical strategy to reduce the risk of passive hemolysis by screening plateletpheresis donors for high-titer ABO antibodies.Transfusion2011;51:92–6.10.1111/j.1537-2995.2010.02759.x368292520576015Search in Google Scholar
Slezak S, Jin P, Caruccio L, et al. Gene and microRNA analysis of neutrophils from patients with polycythemia vera and essential thrombocytosis: down-regulation of micro RNA-1 and -133a. J Transl Med 2009;7:39.SlezakSJinPCaruccioL,Gene and microRNA analysis of neutrophils from patients with polycythemia vera and essential thrombocytosis: down-regulation of micro RNA-1 and -133a.J Transl Med2009;7:39.10.1186/1479-5876-7-39270192519497108Search in Google Scholar
Stroncek DF, Caruccio L, Bettinotti M. CD177: a member of the Ly-6 gene superfamily involved with neutrophil proliferation and polycythemia vera. J Transl Med 2004;2:8.StroncekDFCaruccioLBettinottiM.CD177: a member of the Ly-6 gene superfamily involved with neutrophil proliferation and polycythemia vera.J Transl Med2004;2:8.10.1186/1479-5876-2-841106215050027Search in Google Scholar
Stroncek DF, Procter JL, Moses L, et al. Intravenous Rh immune globulin prevents alloimmunization in D– granulocyte recipients but obscures the detection of an allo-anti-K. Immunohematology 2001;17:37–41.StroncekDFProcterJLMosesL,Intravenous Rh immune globulin prevents alloimmunization in D– granulocyte recipients but obscures the detection of an allo-anti-K.Immunohematology2001;17:37–41.10.21307/immunohematology-2019-541Search in Google Scholar
Wenk RE, McGann H, Gibble J. Haemoglobin A1c in donor erythrocytes. Transfus Med 2011;21:349–50.WenkREMcGannHGibbleJ.Haemoglobin A1c in donor erythrocytes.Transfus Med2011;21:349–50.10.1111/j.1365-3148.2011.01089.x21726305Search in Google Scholar
Chen LN, Collins-Johnson N, Sapp N, et al. How do I structure logistic processes in preparation for outsourcing of cellular therapy manufacturing? Transfusion 2019;59:2506–18.ChenLNCollins-JohnsonNSappN,How do I structure logistic processes in preparation for outsourcing of cellular therapy manufacturing?Transfusion2019;59:2506–18.10.1111/trf.1534931135995Search in Google Scholar
Flegel WA, Castilho L, Delaney M, et al. Molecular immunohaematology round table discussions at the AABB Annual Meeting, Denver 2013. Blood Transfus 2015;13:514–20.FlegelWACastilhoLDelaneyM,Molecular immunohaematology round table discussions at the AABB Annual Meeting, Denver 2013.Blood Transfus2015;13:514–20.Search in Google Scholar
Flegel WA, Natanson C, Klein HG. Does prolonged storage of red blood cells cause harm? Br J Haematol 2014;165:3–16.FlegelWANatansonCKleinHG.Does prolonged storage of red blood cells cause harm?Br J Haematol2014;165:3–16.10.1111/bjh.12747551554424460532Search in Google Scholar
McWilliams B, Triulzi DJ, Waters JH, Alarcon LH, Reddy V, Yazer MH. Trends in RBC ordering and use after implementing adaptive alerts in the electronic computerized physician order entry system. Am J Clin Pathol 2014;141:534–41.McWilliamsBTriulziDJWatersJHAlarconLHReddyVYazerMH.Trends in RBC ordering and use after implementing adaptive alerts in the electronic computerized physician order entry system.Am J Clin Pathol2014;141:534–41.10.1309/AJCPEN6VHT0ECAFI24619755Search in Google Scholar
Salpeter SR, Buckley JS, Chatterjee S. Impact of more restrictive blood transfusion strategies on clinical outcomes: a meta-analysis and systematic review. Am J Med 2014;127:124–31, e3.SalpeterSRBuckleyJSChatterjeeS.Impact of more restrictive blood transfusion strategies on clinical outcomes: a meta-analysis and systematic review.Am J Med2014;127:124–31, e3.10.1016/j.amjmed.2013.09.01724331453Search in Google Scholar
McCullough J, Goldfinger D, Gorlin J, et al. Cost implications of implementation of pathogen-inactivated platelets. Transfusion 2015;55:2312–20.McCulloughJGoldfingerDGorlinJ,Cost implications of implementation of pathogen-inactivated platelets.Transfusion2015;55:2312–20.10.1111/trf.13149469131525989465Search in Google Scholar
Kaherl K. Standards for immunohematology reference laboratories. Bethesda, MD: AABB, 2017.KaherlK.Standards for immunohematology reference laboratories.Bethesda, MD:AABB,2017.Search in Google Scholar